Market
Maca extract (Lepidium meyenii) in Italy is primarily an imported botanical ingredient used in food supplements rather than a domestically produced agricultural commodity. Market access hinges on correct regulatory classification (botanical vs. novel food) and Italy’s food-supplement notification workflow, alongside EU-wide food law, labelling, and health-claim controls. Supply availability is structurally dependent on non-EU Andean sourcing and on supplier capability to provide robust identity, traceability, and safety documentation for batches. The most material commercial risks are regulatory non-compliance (novel-food status, botanicals rules, claims) and quality/safety issues typical of botanical extracts (contaminants, residues, microbiology) under EU controls.
Market RoleNet importer and domestic supplement-formulation/consumer market
Domestic RoleUse as an ingredient in Italian food supplements placed on the market via national notification procedures
Risks
Regulatory Compliance HighNovel-food and botanicals eligibility is the primary deal-breaker risk: if the specific maca preparation (extract type, concentration, plant part, process) is considered a novel food in the EU/Italy or is not eligible under Italy’s botanicals framework for supplements, it cannot be marketed without the appropriate EU authorization and/or national compliance steps, leading to withdrawal, refusal, or enforcement action.Run a pre-market regulatory determination using the EU Novel Food framework and the European Commission Novel Food status Catalogue, and align Italian supplement use with Ministero della Salute botanicals rules; keep a documented dossier supporting the chosen classification and intended use.
Food Safety MediumBotanical extracts can trigger non-compliance findings under EU food safety controls (e.g., contaminants, pesticide residues, microbiological issues) and may be sampled under risk-based official controls on imported food of non-animal origin, causing delays, rejections, or recalls.Implement importer QA release (identity + contaminants/residues + microbiology testing) and qualify suppliers with documented GMP/HACCP controls and robust COA/traceability.
Labelling And Claims MediumMarketing maca-containing supplements with non-authorised or misleading health claims (e.g., sexual function/energy/disease-related implications) can lead to enforcement under EU claims rules and under supplement labelling restrictions, disrupting commercialization even when the ingredient itself is compliant.Pre-clear all label and advertising claims against Regulation (EC) No 1924/2006 and supplement labelling rules; maintain Italian NSIS notification documentation for products subject to notification.
Reputational MediumMaca has documented biopiracy controversy narratives (patent-system disputes involving Peruvian genetic resources/traditional knowledge). Weak origin transparency can create reputational and procurement risk for Italian buyers and brands.Strengthen provenance documentation (origin, chain-of-custody, supplier declarations) and adopt responsible sourcing and benefit-sharing-aware procurement policies for Andean-origin botanicals.
Documentation Gap MediumDocumentation mismatches (botanical identity, plant part, extract ratio/solvent, intended use as food vs. supplement, and supporting safety/history evidence) can cause customs delays, buyer rejection, or regulatory scrutiny in Italy’s supplement notification context.Standardize technical datasheets and COAs (including botanical name, part used, extraction method, markers where applicable, allergen status) and ensure consistency across label, invoice, and import documentation.
Sustainability- High-Andes biodiversity and resource-pressure concerns linked to rapid commercialization of maca value chains; responsible sourcing and traceability to origin are often needed to address buyer and stakeholder scrutiny.
- Genetic resource and traditional-knowledge appropriation (biopiracy) concerns have been explicitly raised by Peru in relation to maca, creating reputational risk for poorly documented supply chains.
Labor & Social- Indigenous knowledge and benefit-sharing sensitivity: maca is associated with Peruvian genetic resources and traditional knowledge, and Peru has actively challenged perceived biopiracy in patent systems; buyers may require stronger provenance and documentation to manage reputational risk.
FAQ
Is maca extract considered a novel food in Italy and the EU?It depends on the specific maca preparation (plant part, extraction method, concentration, and evidence of significant EU consumption before 15 May 1997). The EU Novel Food framework (Regulation (EU) 2015/2283) applies, and the European Commission’s Novel Food status Catalogue is an orientation tool; for Italy, botanicals used in supplements are also governed by national rules (including the Ministero della Salute Decree of 10 August 2018).
Do maca-containing food supplements need to be notified before being sold in Italy?Yes. For food supplements and other foods subject to notification, the operator must transmit the product label to the Italian Ministry of Health via the electronic system “NSIS – Alimenti soggetti a notifica” before first commercialization; the notification is an obligation and does not itself constitute an approval.
What are the main compliance checks Italian importers should expect for maca extract used in supplements?Importers should be prepared for risk-based official controls on imported food of non-animal origin and for EU food-law compliance on contaminants, pesticide residues, and microbiological safety controls. They should also ensure labels and any marketing claims comply with EU rules on food information (Regulation (EU) 1169/2011) and on nutrition and health claims (Regulation (EC) 1924/2006).